Angiogenesis and Cardiac Growth as Heart Failure Therapy
Angiogenesis and Cardiac Growth as Heart Failure Therapy
批准号:
7414373
负责人:
Y Joseph Woo
金额:
$13.25万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2009-04-30
关键词:
AchievementAdenovirus VectorAdenovirusesApoptosisApoptoticAttenuatedAwardBiological FactorsBlood flowCa(2+)-Transporting ATPaseCalciumCaliberCardiacCardiac MyocytesCardiac OutputCardiomyopathiesCardiomyoplastyCardiovascular DiseasesCaringCell CycleChairpersonClinicalCongestive Heart FailureCoupledDepthDevicesDilatation - actionEnvironmentGene ExpressionGoalsGrowthHealthHeartHeart TransplantationHeart failureHepatocyte Growth FactorHypertrophyInfarctionInstitutionIschemiaKnowledgeLeft Ventricular DysfunctionLifeLocalizedMechanicsMedicalMolecularMonitorMyocardialMyocardial IschemiaMyocardial perfusionNatural regenerationNumbersOperative Surgical ProceduresPathological DilatationPropertyProtein OverexpressionRecombinantsResearchResearch PersonnelResearch Project GrantsResearch TechnicsRodent ModelSomatotropinStructureTestingTimeTissue EngineeringTraining and EducationVascular blood supplyVascularizationVentricularVentricular DysfunctionVentricular FunctionVentricular RemodelingViralaging populationangiogenesiscareerdesigngene therapyin vivoinnovationmortalitynovelpressurepreventskillstooltransgene expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Cardiovascular disease is the leading cause of mortality worldwide. In the U.S., one million people die annually of cardiovascular disease, five million people live with congestive heart failure, and another five million have significant asymptomatic left ventricular dysfunction soon to progress to heart failure, numbers that are predicted to rise dramatically with the progressively aging population. Current therapies for heart failure consist of pharmacologic optimization of preload and afterload together with very limited reconstructive or replacement options. The overall objective of the proposed research project is to augment native cardiomyocyte function through two interrelated molecular strategies of inducing angiogenesis and localized myocardial growth. In a rodent model of ischemic cardiomyopathy, recombinant adenoviruses will be used to provide high-level, localized gene expression of the angiogenic agent hepatocyte growth factor and the trophic agent growth hormone. Effects on myocardial function will then be assessed in vivo with an intracavitary pressure volume conductance microcatheter and an ascending aortic cardiac output monitor. Effects on ventricular remodeling will also be evaluated. Specific mechanisms of action pertaining to reversal of myocardial ischemia, anti-apoptosis, and hypercontractility will be studied in-depth. The ultimate goal will be to develop an integrated heart failure therapy which promotes native cardiomyocyte growth coupled with enhanced myocardial blood flow.
The candidate seeks to utilize the time and opportunities provided by this proposed research career award to engage in a concentrated period of scholarly activity dedicated to studying basic molecular and cellular mechanisms in heart failure, to design innovative treatment strategies pertinent to clinical care, to obtain additional structured didactic education and training, to acquire new scientific knowledge and research techniques, and to develop critical skills towards becoming a competitive, independent investigator. The candidate's institution, sponsor, and chairman provide a uniquely supportive, high-caliber, educationally stimulating environment highly conducive to the achievement of these goals.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.hlc.2005.12.004
发表时间:
2006-04-01
期刊:
Heart, lung & circulation
影响因子:
--
作者:
[Cohen, Jeffrey E, Atluri, Pavan, Woo, Y Joseph]
通讯作者:
Woo, Y Joseph
DOI:
10.1016/j.hlc.2004.12.021
发表时间:
2005-03-01
期刊:
Heart, lung & circulation
影响因子:
--
作者:
[Taylor, Matthew D, Grand, Todd J, Woo, Y Joseph]
通讯作者:
Woo, Y Joseph
Off-pump revascularization for significant left ventricular dysfunction.
显着左心室功能障碍的非体外血运重建。
DOI:
10.1177/021849230601400408
发表时间:
2006
期刊:
Asian cardiovascular & thoracic annals
影响因子:
0.7
作者:
[Woo,YJoseph, Grand,ToddJ, Liao,GeorgeP, Panlilio,CorinnaM]
通讯作者:
Panlilio,CorinnaM
DOI:
10.2478/s11658-006-0058-7
发表时间:
2007
期刊:
Cellular & molecular biology letters
影响因子:
8.3
作者:
[Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, Hiesinger W, Cohen JE, Joseph Woo Y]
通讯作者:
Joseph Woo Y
DOI:
10.1053/j.semtcvs.2007.12.003
发表时间:
2007
期刊:
Seminars in thoracic and cardiovascular surgery
影响因子:
2.5
作者:
[Woo,YJoseph]
通讯作者:
Woo,YJoseph
Biomechanical Optimization of Cardiac Valve Repair Operations
-
批准号:10684179
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2020
-
负责人:Y Joseph Woo
-
依托单位:
Biomechanical Optimization of Cardiac Valve Repair Operations
-
批准号:10469367
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2020
-
负责人:Y Joseph Woo
-
依托单位:
Biomechanical Optimization of Cardiac Valve Repair Operations
-
批准号:10158270
-
项目类别:
-
资助金额:$68.97万
-
财政年份:2020
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic tissue engineering to limit post-infarction ventricular remodeling
-
批准号:8230794
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic tissue engineering to limit post-infarction ventricular remodeling
-
批准号:7460022
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING
-
批准号:9095414
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery
-
批准号:9887268
-
项目类别:
-
资助金额:$62.02万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic tissue engineering to limit post-infarction ventricular remodeling
-
批准号:7586585
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic tissue engineering to limit post-infarction ventricular remodeling
-
批准号:8036046
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic tissue engineering to limit post-infarction ventricular remodeling
-
批准号:7772268
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
ANGIOGENIC TISSUE ENGINEERING TO LIMIT POST-INFARCTION VENTRICULAR REMODELING
-
批准号:8853534
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery
-
批准号:10357672
-
项目类别:
-
资助金额:$62.54万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery
-
批准号:10585926
-
项目类别:
-
资助金额:$62.15万
-
财政年份:2008
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenesis and Cardiac Growth as Heart Failure Therapy
-
批准号:6764935
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2004
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenesis and Cardiac Growth as Heart Failure Therapy
-
批准号:7226256
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2004
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenesis and Cardiac Growth as Heart Failure Therapy
-
批准号:6888086
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2004
-
负责人:Y Joseph Woo
-
依托单位:
Angiogenesis and Cardiac Growth as Heart Failure Therapy
-
批准号:7060921
-
项目类别:
-
资助金额:$13.25万
-
财政年份:2004
-
负责人:Y Joseph Woo
-
依托单位:
海外基金